Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure

doi:10.4252/wjsc.v12.i4.277

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9259)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

560

WORD

128

HTML

4880

Figures (1-2)

324

Tables (1-4)

300

Sum=6192

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

404

Download

760

Sum=1164

Publishing Process of This Article

Item

Count

Browse

687

Download

1216

Sum=1903

Apr 26, 2020 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Apr 26, 2020; 12(4): 277-287
Published online Apr 26, 2020. doi: 10.4252/wjsc.v12.i4.277

Full Size Figure Download Figure

Figure 2 Results of ovarian tissue staining (Haematoxylin-eosin staining). A: Negative control group; B: Model group; C: Human umbilical cord mesenchymal stem cells group; D: Positive control group (100×); E: Negative control group; F: Model group; G: Human umbilical cord mesenchymal stem cells group; H: Positive control group (200×).

Citation: Shen J, Cao D, Sun JL. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure. World J Stem Cells 2020; 12(4): 277-287
URL: https://www.wjgnet.com/1948-0210/full/v12/i4/277.htm
DOI: https://dx.doi.org/10.4252/wjsc.v12.i4.277